Combination chemotherapy for hepatitis B virus: The final solution?

[11] Lamivudine as initial treatment for chronic hepatitis B in the United States [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) : 1256 - 1263

[12] Fontana RJ, 1997, HEPATOLOGY, V26, P234

[13] Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 749 - 754

[14] COMPARATIVE BIOLOGY AND PATHOGENESIS OF AIDS AND HEPATITIS-B VIRUSES - RELATED BUT DIFFERENT [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) : 1409 - 1419

[15] Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks [J]. ANTIVIRAL RESEARCH, 2000, 45 (01) : 19 - 32

[16] The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2′-deoxy-3′-thiacytidine and a reduced ability to synthesize viral DNA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2128 - 2131

[17] Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study [J]. HEPATOLOGY, 2000, 32 (02) : 394 - 399

[18] Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (03) : 536 - 550

[19] LONG-TERM FOLLOW-UP OF CHRONIC HEPATITIS-B PATIENTS TREATED WITH INTERFERON-ALFA [J]. GASTROENTEROLOGY, 1993, 105 (06) : 1833 - 1838

[20] Update on diagnosis, management, and prevention of hepatitis B virus infection [J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (02) : 351 - +

[11] Lamivudine as initial treatment for chronic hepatitis B in the United States [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) : 1256 - 1263

[12] Fontana RJ, 1997, HEPATOLOGY, V26, P234

[13] Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 749 - 754

[14] COMPARATIVE BIOLOGY AND PATHOGENESIS OF AIDS AND HEPATITIS-B VIRUSES - RELATED BUT DIFFERENT [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) : 1409 - 1419

[15] Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks [J]. ANTIVIRAL RESEARCH, 2000, 45 (01) : 19 - 32

[16] The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2′-deoxy-3′-thiacytidine and a reduced ability to synthesize viral DNA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2128 - 2131

[17] Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study [J]. HEPATOLOGY, 2000, 32 (02) : 394 - 399

[18] Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (03) : 536 - 550

[19] LONG-TERM FOLLOW-UP OF CHRONIC HEPATITIS-B PATIENTS TREATED WITH INTERFERON-ALFA [J]. GASTROENTEROLOGY, 1993, 105 (06) : 1833 - 1838

[20] Update on diagnosis, management, and prevention of hepatitis B virus infection [J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (02) : 351 - +